Use our development programs at a very early stage by entering into a long-term strategic partnership

Kinase inhibitor development programs Technology Partnership


License technologies, drug candidates and radiotracers from Oncodesign’s portfolio

Kinase inhibitors in oncology, CNS and inflammation Technologies



The power and selectivity of Nanocyclix® molecules applied to the entire kinome. Learn More


Oncodesign News

[Congress] Microbiota & Health Day - 26 January, 2021

Tailor-made strategies to your needs for the investigation of the efficacy of your bacteria-based treatments and/or the effect of your therapies on microbiota.

Learn more

[Congress] J.P. Morgan Healthcare Conference & Biotech Showcase, 11-15 January, 2021

Seeking for partners on drug discovery programs based on our Nanocyclix platform as next-generation kinase inhibitors.


Learn more

[Congress] [FR] E-Senotech, 1st Congress on Breast Health in the Digital Age

Connected objects, artificial intelligence and big data are an integral part of our daily life.

Learn more

Word from the Chairman

Since our April 2014 IPO, we have accelerated our development and have become an international biopharma company specialized in precision medicine pursuing ambitious development objectives underpinned by acquisition-led growth and investments in innovative therapeutic research programs.

Learn More



Oncodesign’s mission is to discover innovative new therapies effective against cancer and serious illnesses with unmet medical needs.

Oncodesign has opted to take the time to build up all the dimensions of its organization—scientific, technical, business, starting with the most crucial one, the human dimension.

Our values Job offers/work-study arrangements Internship available Spontaneous applications

Contact Us

Invalid Input

Invalid Input

Invalid Input

Please write a subject for your message.

Please let us know your message.

Invalid Input

Sales team

If you have any questions, please contact the member of our sales team responsible for your geographical region, and we will get back to you as swiftly as we can.

Oncodesign sales team

Connect with us now